The Road Ahead: Oral Dominance Is Not Inevitable Despite the growing commercial momentum surrounding oral GLP-1 therapies, the segment continues to face several important challenges that may affect long-term adoption and market expansion
According to Novo Nordisk, the results showed a significant reduction in weight and HbA1c in adults with type 2 diabetes (T2D)
If you are wondering whether a prescription path is right for you, you can also complete the free assessment quiz to review your options with a licensed provider
While mice and rats do not vomit, GLP-1R agonism induces emesis in the musk shrew and is associated with an increase in cFOS staining in the AP, nucleus of the solitary tract (NTS), DMH, VMH, lateral hypothalamus (LH), and PVH that is blocked by GLP-1R antagonism (77)
These medications are designed for long-term use, and weight tends to return once they are discontinued unless the underlying metabolic drivers have also been addressed